These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24632587)

  • 1. Negative association of serum IL-6 and IL-17 with type-II diabetes retinopathy.
    Afzal N; Zaman S; Asghar A; Javed K; Shahzad F; Zafar A; Nagi AH
    Iran J Immunol; 2014 Mar; 11(1):40-8. PubMed ID: 24632587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse relationship of serum IL-17 with type-II diabetes retinopathy.
    Nadeem A; Javaid K; Sami W; Zafar A; Jahan S; Zaman S; Nagi A
    Clin Lab; 2013; 59(11-12):1311-7. PubMed ID: 24409666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enumeration of CD4(+)CD25(+)T regulatory cells in Type-II diabetes retinopathy.
    Afzal N; Javaid K; Zaman S; Zafar A; Nagi AH
    Pak J Pharm Sci; 2014 Sep; 27(5):1191-7. PubMed ID: 25176359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms in type-2 diabetic retinopathy.
    Afzal N; Zaman S; Shahzad F; Javaid K; Zafar A; Nagi AH
    J Pak Med Assoc; 2015 Feb; 65(2):159-63. PubMed ID: 25842551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
    Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
    Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irisin modulates the association of interleukin-17A with the presence of non-proliferative diabetic retinopathy in patients with type 2 diabetes.
    Wang C; Wang L; Liu J; Song J; Sun Y; Lin P; Liang K; Liu F; He T; Sun Z; Hou X; Chen L
    Endocrine; 2016 Aug; 53(2):459-64. PubMed ID: 26940815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oxidative stress in diabetic retinopathy.
    Gürler B; Vural H; Yilmaz N; Oguz H; Satici A; Aksoy N
    Eye (Lond); 2000 Oct; 14 Pt 5():730-5. PubMed ID: 11116694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Nough H; Nemati M; Rezayati MT
    Anadolu Kardiyol Derg; 2009 Apr; 9(2):75-83. PubMed ID: 19357047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine-immune disorder in type 2 diabetic patients with retinopathy.
    Obulkasim M; Turdi A; Amat N; Haxim M; Eziz R; Haji H; Li L; Chen X; Upur H; Ren J
    Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):229-32. PubMed ID: 21281334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of free L-carnitine levels in type II diabetic women with and without complications.
    Poorabbas A; Fallah F; Bagdadchi J; Mahdavi R; Aliasgarzadeh A; Asadi Y; Koushavar H; Vahed Jabbari M
    Eur J Clin Nutr; 2007 Jul; 61(7):892-5. PubMed ID: 17311064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus].
    Yang G; Lu J; Pan C
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):34-8. PubMed ID: 11940295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
    Cyganek K; Mirkiewicz-Sieradzka B; Malecki MT; Wolkow P; Skupien J; Bobrek J; Czogala M; Klupa T; Sieradzki J
    Acta Diabetol; 2006 Dec; 43(4):114-9. PubMed ID: 17211561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
    Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy.
    Blum A; Socea D; Ben-Shushan RS; Keinan-Boker L; Naftali M; Segol G; Tamir S
    Eur Cytokine Netw; 2012; 23(4):158-62. PubMed ID: 23328414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Of Serum Total Bilirubin Level With Diabetic Retinopathy In Type 2 Diabetes Mellitus.
    Ghaffar T; Marwat ZI; Ullah F; Khan S; Hassan Aamir AU
    J Ayub Med Coll Abbottabad; 2016; 28(3):537-541. PubMed ID: 28712230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.